Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenome-Driven Strategies for Personalized Cancer Immunotherapy

1 Dec 2023

Abstract excerpt

Fighting cancer remains one of the greatest challenges for science in the 21st century. Advances in immunotherapy against different types of cancer have greatly contributed to the treatment, remission, and cure of patients. In this context, knowledge of epigenetic phenomena, their relationship with tumor cells and how the immune system can be epigenetically modulated represent some of the greatest advances in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38058537
DOI: 10.2147/cmar.s272031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenome-Driven Strategies for Personalized Cancer ImmunotherapyPMID 38058537Read ↗

Epigenetic Perspective of Immunotherapy for CancersSemantic proximity Read ↗

Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitorsSemantic proximity Read ↗

Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy.Semantic proximity Read ↗

Epigenetic modulation in cancer immunotherapySemantic proximity Read ↗

The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.Semantic proximity Read ↗

The cancer epigenome: Concepts, challenges, and therapeutic opportunities.Semantic proximity Read ↗

Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification InhibitorsSemantic proximity Read ↗

Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade ResponseSemantic proximity Read ↗

Epigenetic Mechanisms of Resistance to Immune Checkpoint InhibitorsSemantic proximity Read ↗

DNA Methylation: From Cancer Biology to Clinical PerspectivesSemantic proximity Read ↗

Epigenetics and OncologySemantic proximity Read ↗

Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on BiomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.